Outset Medical Financials - Benzinga

Outset Medical Inc

OMNASDAQ

Trade with Public

Trade with Public

$3.67

0.030.82%

At close: Sep 1, 5:00 PM EST

$3.83

0.195.22%

Pre-Market: 4:09 AM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Outset Medical Financials

Outset Medical (OM) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Outset Medical Affirms FY2026 Sales Guidance of $125.000M-$130.000M vs $126.633M Est

Outset Medical (NASDAQ:OM) affirms FY2026 sales outlook from $125.000 million-$130.000 million to $125.000 million-$130.000 million vs $126.633 million estimate.

Benzinga Newsdesk

PRO
Outset Medical Q2 Adj. EPS $(0.80) Misses $(0.72) Estimate, Sales $31.635M Beat $29.833M Estimate

Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.80) per share which missed the analyst consensus estimate of $(0.72) by 11.11 percent. This is a 4.76 percent increase over losses of $(0.84) per share from

Benzinga Newsdesk

PRO
Outset Medical Affirms FY2026 Sales Guidance of $125.000M-$130.000M vs $126.767M Est

Outset Medical (NASDAQ:OM) affirms FY2026 sales outlook from $125.000 million-$130.000 million to $125.000 million-$130.000 million vs $126.767 million estimate.

Benzinga Newsdesk

PRO
Outset Medical Q1 Adj. EPS $(0.83) Misses $(0.79) Estimate, Sales $27.863M Miss $28.900M Estimate

Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.83) per share which missed the analyst consensus estimate of $(0.79) by 5.06 percent. This is a 74.38 percent increase over losses of $(3.24) per share from the

Benzinga Newsdesk

Outset Medical Q4 Earnings Report: What Investors Need to Know

Benzinga Insights

PRO
Outset Medical Sees FY2026 Sales $125.000M-$130.000M vs $127.650M Est

Outset Medical (NASDAQ:OM) sees FY2026 sales of $125.000 million-$130.000 million vs $127.650 million analyst estimate.

Benzinga Newsdesk